Gilead to assess remdesivir in paediatric Covid-19 patients - Clinical Trials Arena 19-Jun-2020

Gilead to assess remdesivir in paediatric Covid-19 patients - Clinical Trials Arena

Gilead Sciences is set to conduct a Phase II/III trial of its investigational drug remdesivir to treat paediatric patients hospitalised due to Covid-19.

More...